TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21644803

Group type: EXPERIMENTAL
Intervention: Facebook profiles showing older peers drinking
Number of subjects: 189

Group type: COMPARATOR
Intervention: Facebook profiles showing older peers not drinking
Number of subjects: 189
Study: 19567857

Group type: EXPERIMENTAL
Intervention: Immobilisation in external rotation (15 to 20 degrees)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Immobilisation in internal rotation (traditional brace)
Number of subjects: 51
Study: 17327338

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg q.d. and 60 mg b.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study: 16083193

Group type: EXPERIMENTAL
Intervention: Creatine supplement (5 g with orange solution 15 g, twice per day for 7 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (orange solution only)
Number of subjects: 38
Study: 11109037

Group type: EXPERIMENTAL
Intervention: Skin clip technique
Number of subjects: 162

Group type: COMPARATOR
Intervention: Subcuticular suture technique
Number of subjects: 162
Study: 8922007

Group type: EXPERIMENTAL
Intervention: Subcutaneous lidocaine (SQL) pretreatment
Number of subjects: 110

Group type: COMPARATOR
Intervention: No pretreatment (Control)
Number of subjects: 110
Study: 1550365

Group type: EXPERIMENTAL
Intervention: Extracorporeal photochemotherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: D‐penicillamine (maximum dose of 750 mg/d)
Number of subjects: 79

Group type: COMPARATOR
Intervention: D‐penicillamine
Number of subjects: 79
Study: 2931846

Group type: EXPERIMENTAL
Intervention: Chrysanol (1.5 ml of a 5% solution)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Myochrysine (50 mg, 25 mg metallic gold once a week)
Number of subjects: 50
Study: 30964227

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined fractional CO2 laser and PRP
Number of subjects: 30
Study: 30564154

Group type: EXPERIMENTAL
Intervention: IMPaCT psychosocial health intervention
Number of subjects: 293

Group type: COMPARATOR
Intervention: Eligible comparator population
Number of subjects: 293
Study: 28169258

Group type: EXPERIMENTAL
Intervention: Adjunctive photodynamic therapy (PDT) using 810 nm diode laser and Indocyanine green as photosensitizer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scaling and root‐planing (SRP)
Number of subjects: 0
Study: 25453731

Group type: EXPERIMENTAL
Intervention: Statins (3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitors) ± ezetimibe
Number of subjects: 0
Study: 22421716

Group type: EXPERIMENTAL
Intervention: Gum chewing thrice a day for 1 hour each time starting 6 hours after surgery until the passage of first flatus
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard postoperative treatment
Number of subjects: 100
Study: 20533219

Group type: EXPERIMENTAL
Intervention: Elimination diet (soy formula or casein hydrolysate)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no elimination diet)
Number of subjects: 92
Study: 17617906

Group type: EXPERIMENTAL
Intervention: PDA followed by PDA survey
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: PDA followed by paper survey
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: paper followed by PDA survey
Number of subjects: 152
Study: 16301881

Group type: EXPERIMENTAL
Intervention: Psychotic depression after ECT
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nonpsychotic depression after ECT
Number of subjects: 59
Study: 12002352

Group type: EXPERIMENTAL
Intervention: Intravesical oxybutynin (5 mg/30 ml three times daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9813559

Group type: EXPERIMENTAL
Intervention: L‐NMMA (nitric oxide synthase inhibitor)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (endothelium independent vasodilator)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Serotonin (endothelium dependent vasodilator)
Number of subjects: 12
Study: 7653804

Group type: EXPERIMENTAL
Intervention: Alfentanil 50 micrograms/kg as a rapid infusion over 10 min during CPB (normothermic)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alfentanil 50 micrograms/kg as a rapid infusion over 10 min during CPB (hypothermic)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alfentanil 50 micrograms/kg as a rapid infusion over 10 min (nonbypass group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alfentanil (normothermic CPB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alfentanil (hypothermic CPB)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alfentanil (nonbypass group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Alfentanil (normothermic vs hypothermic CPB)
Number of subjects: 36
Study: 2496420

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo gum (0 mg)
Number of subjects: 6
Study: 828982

Group type: EXPERIMENTAL
Intervention: Group I: saline solution (1000‐1500 ml), glucose (100‐150 g), and amino acids (15‐30 g) per day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Group II: 40‐50 Cal/kg per day (dextrose about 15 g/kg per day), about 2 g of amino acids/kg/day and about 40‐50 ml water/kg/day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Hyperalimentation (both treatments sequentially)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Both groups (comparison)
Number of subjects: 44
Study: 31077251

Group type: EXPERIMENTAL
Intervention: Mean Rank Method (MRM)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Ordinary Least Squares (OLS)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Equi-percentile Method (EPM)
Number of subjects: 421
Study: 29154057

Group type: EXPERIMENTAL
Intervention: Far-infrared ray (FIR) patches applied to 98 MTrPs for 24 hours in the intervention group (61 patients)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo patches applied to 91 MTrPs in the control group (57 patients)
Number of subjects: 125
Study: 24458801

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (RSV) 10 mg/d
Number of subjects: 262

Group type: COMPARATOR
Intervention: Rosuvastatin (RSV) 10 mg/d plus Ezetimibe (EZT) 10 mg/d
Number of subjects: 262

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (RSV) 10 mg/d and Ezetimibe (EZT) 10 mg/d
Number of subjects: 262
Study: 23619829

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided TAP block anesthesia
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional spinal anesthesia
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study: 21330640

Group type: EXPERIMENTAL
Intervention: Valsartan (320 mg daily)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 19387176

Group type: EXPERIMENTAL
Intervention: Sugammadex (16 mg/kg) administered 3 min after rocuronium (1.2 mg/kg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Succinylcholine (1 mg/kg)
Number of subjects: 115
Study: 17291177

Group type: EXPERIMENTAL
Intervention: Inhalation of an inert placebo described as a suspected environmental toxin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observation of a female confederate inhaling the substance and displaying symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in reported symptoms
Number of subjects: 0
Study: 14699004

Group type: EXPERIMENTAL
Intervention: Combination of ramipril (10 mg/d) and atorvastatin (40 mg/d)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 10877131

Group type: EXPERIMENTAL
Intervention: Ebastine 20 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9060538

Group type: EXPERIMENTAL
Intervention: Surgical second look (SSL)
Number of subjects: 102

Group type: COMPARATOR
Intervention: No surgical second look (follow-up evaluation only)
Number of subjects: 102
Study: 8445234

Group type: EXPERIMENTAL
Intervention: alpha-interferon with or without prednisone priming
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control (negative for hepatitis B virus deoxyribonucleic acid)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: alpha-interferon with or without steroid priming
Number of subjects: 272
Study: 3725503

Group type: EXPERIMENTAL
Intervention: Standard magnesium-aluminum hydroxide antacids at a dose of 0.5 mL/kg per dose
Number of subjects: 0
Study: 30630801

Group type: EXPERIMENTAL
Intervention: Breast-conserving therapy integrated with neoadjuvant chemotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Radical resection of breast cancer
Number of subjects: 68
Study: 28667881

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Supportive therapy (wait-list group)
Number of subjects: 18
Study: 26209857

Group type: EXPERIMENTAL
Intervention: Varenicline (2mg/d)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 24565125

Group type: EXPERIMENTAL
Intervention: Group A (stylet replacement before needle removal)
Number of subjects: 630

Group type: COMPARATOR
Intervention: Group B (needle removal without stylet replacement)
Number of subjects: 630
Study: 21148135

Group type: EXPERIMENTAL
Intervention: Bronchodilation
Number of subjects: 201

Group type: COMPARATOR
Intervention: Pulmonary rehabilitation
Number of subjects: 201
Study: 18507868

Group type: EXPERIMENTAL
Intervention: BB therapy with thrice-daily insulin aspart and once-daily basal insulin (BB group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional therapy with twice-daily biphasic insulin analogue (30 Mix group)
Number of subjects: 42
Study: 17320017

Group type: EXPERIMENTAL
Intervention: Nursing interventions directed to the patient and environment for maintaining time-space orientation and cognitive functions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48
Study: 12663006

Group type: EXPERIMENTAL
Intervention: Nasal hinge LASIK
Number of subjects: 30

Group type: COMPARATOR
Intervention: Superior hinge LASIK
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 10379622

Group type: EXPERIMENTAL
Intervention: Higher nicotine yield cigarettes (1.1 mg nicotine yield)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Very low nicotine yield cigarette (0.05 mg nicotine yield)
Number of subjects: 0
Study: 8950781

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) with low estrogen formulations containing norgestimate or gestodene
Number of subjects: 0
Study: 1850722

Group type: EXPERIMENTAL
Intervention: Full dose chemotherapy (60 mg/m2 doxorubicin and 500 mg/m2 5-fluorouracil every 3 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 131I antiferritin administration every 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 131I antiferritin administration
Number of subjects: 0
Study: 6890374

Group type: EXPERIMENTAL
Intervention: Lofexidine (300 micrograms)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Clonidine (300 micrograms)
Number of subjects: 6
Study: 30644774

Group type: EXPERIMENTAL
Intervention: New Beginnings Program (NBP), 10 sessions
Number of subjects: 830

Group type: COMPARATOR
Intervention: Active 2‐session comparison condition (control)
Number of subjects: 830
Study: 30663595

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28375486

Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy (nCT)
Number of subjects: 267

Group type: COMPARATOR
Intervention: neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 267
Study: 24923998

Group type: EXPERIMENTAL
Intervention: Brush-based self-sampling device
Number of subjects: 30130

Group type: COMPARATOR
Intervention: Lavage-based self-sampling device
Number of subjects: 30130
Study: 23212275

Group type: EXPERIMENTAL
Intervention: Gd-DOTA-enhanced MRI
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (unenhanced MRI)
Number of subjects: 114
Study: 21779745

Group type: EXPERIMENTAL
Intervention: Tooth/implant supported restoration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Implant only restoration
Number of subjects: 20
Study: 19508580

Group type: EXPERIMENTAL
Intervention: Silicone gel applied to the wound twice a day for 60 days after removal of stitches
Number of subjects: 110

Group type: COMPARATOR
Intervention: Zinc oxide cream
Number of subjects: 110
Study: 16705264

Group type: EXPERIMENTAL
Intervention: Modified LF‐ASD design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Previous LF‐ASD design
Number of subjects: 0
Study: 14969652

Group type: EXPERIMENTAL
Intervention: Sustained audit/feedback program
Number of subjects: 22000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22000
Study: 12490682

Group type: COMPARATOR
Intervention: High-dose dialysis
Number of subjects: 1846

Group type: COMPARATOR
Intervention: High-flux dialyzer
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Standard-dose dialysis
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Low-flux dialyzer
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Dose and flux interventions
Number of subjects: 1846
Study: 9813403

Group type: EXPERIMENTAL
Intervention: Immediate postictal neuropsychological examination
Number of subjects: 17
Study: 7616311

Group type: EXPERIMENTAL
Intervention: Choline supplementation (20 mg/kg body wt) in young adult women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choline supplementation (2.5 g/kg diet) in Sprague-Dawley rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Choline supplementation (3 g/kg diet) in guinea pigs
Number of subjects: 0
Study: 2092306

Group type: EXPERIMENTAL
Intervention: Nursing intervention at 30 days postinfarction
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Perceived beliefs of others
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Attitude
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 51
Study: 203998

Group type: EXPERIMENTAL
Intervention: Corticotropin (ACTH) 80 units intramuscularly daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hydrocortisone 400 mg infused intravenously over 24 hours
Number of subjects: 16
Study: 7079035

Group type: EXPERIMENTAL
Intervention: Parent training (biweekly home visits for caregiving and sensorimotor exercises)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paid parent training as teacher's aides in the infant nursery
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (CETA-paid teacher's aides in a medical school infant nursery)
Number of subjects: 80
Study: 31424503

Group type: EXPERIMENTAL
Intervention: Furosemide withdrawal (n=95)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Furosemide maintenance (n=93)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 188
Study: 29299602

Group type: EXPERIMENTAL
Intervention: UW‐IPASS standardized handoff curriculum
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 106
Study: 27253202

Group type: EXPERIMENTAL
Intervention: ARC intervention
Number of subjects: 605

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 605
Study: 25170902

Group type: EXPERIMENTAL
Intervention: DNA-based dietary advice report
Number of subjects: 138

Group type: COMPARATOR
Intervention: General dietary advice report (Control)
Number of subjects: 138
Study: 22500381

Group type: EXPERIMENTAL
Intervention: Erzhi Tiangui Granule combined with Western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 60
Study: 20601398

Group type: EXPERIMENTAL
Intervention: Odstock dropped foot stimulator (ODFS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Physiotherapy exercises
Number of subjects: 64
Study: 18048633

Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call)
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls)
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Brief intervention (one 15-minute call) without NRT
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Brief intervention (one 15-minute call) with NRT
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call) without NRT
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Moderate intervention (one 30-minute call and a follow-up call) with NRT
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls) without NRT
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Intensive intervention (five proactive calls) with NRT
Number of subjects: 4614
Study: 16225522

Group type: EXPERIMENTAL
Intervention: Lidocaine suppositories (60 mg) applied 1 or 2 hours before biopsy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine suppositories (60 mg) applied 1 hour before biopsy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine gel (2% - 200 mg) applied 10 minutes before biopsy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 100
Study: 11984384

Group type: EXPERIMENTAL
Intervention: Protocols for data collection, training of data collectors, and data monitoring
Number of subjects: 0
Study: 10432030

Group type: EXPERIMENTAL
Intervention: Vaccine (30 microg each of gB2 and gD2, administered at months 0, 1, and 6)
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Placebo (citrate buffer vehicle)
Number of subjects: 2268

Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2268
Study: 8642806

Group type: COMPARATOR
Intervention: Rilmenidine (1 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clonidine (300 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rilmenidine (2 mg)
Number of subjects: 12
Study: 2155756

Group type: EXPERIMENTAL
Intervention: Otomize spray (neomycin/dexamethasone), administered 3 times daily for 10 days
Number of subjects: 187

Group type: COMPARATOR
Intervention: Otosporin drops (neomycin/polymyxin B/hydrocortisone), administered 3 times daily for 10 days
Number of subjects: 187
Study: 7435249

Group type: EXPERIMENTAL
Intervention: Melperone, 50 mg i.v.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 30946197

Group type: EXPERIMENTAL
Intervention: Flexible locked intramedullary nail
Number of subjects: 72

Group type: COMPARATOR
Intervention: Anatomically contoured locked plate
Number of subjects: 72
Study: 28585351

Group type: EXPERIMENTAL
Intervention: Representation scaffolding during case processing
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no scaffolding)
Number of subjects: 88
Study: 26446479

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg kg(‐1) hr(‐1))
Number of subjects: 115

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 115
Study: 23704196

Group type: EXPERIMENTAL
Intervention: Arm A: 5‐fluorouracil, epirubicin, cyclophosphamide (FEC) + trastuzumab (H) + pertuzumab (P) ×3 → docetaxel (T) + H + P ×3
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Arm B: FEC ×3 → T + H + P ×3
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Arm C: T + carboplatin + H (TCH) + P ×6
Number of subjects: 225
Study: 21551394

Group type: EXPERIMENTAL
Intervention: Patient-centered care
Number of subjects: 509
Study: 19157672

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide bleaching agent
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo agent
Number of subjects: 30
Study: 17846068

Group type: EXPERIMENTAL
Intervention: Facio‐oral tract therapy for three weeks (15 sessions of 1 hour each)
Number of subjects: 10
Study: 15142200

Group type: EXPERIMENTAL
Intervention: Esomeprazole 2 x 20 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Esomeprazole 1 x 40 mg
Number of subjects: 13
Study: 12575590

Group type: EXPERIMENTAL
Intervention: Huancongdan capsule (HCDC)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Naofukang (Control)
Number of subjects: 52
Study: 9389288

Group type: EXPERIMENTAL
Intervention: Intranasal glucocorticoid (beclomethasone dipropionate, 400 microg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8317687

Group type: EXPERIMENTAL
Intervention: 40 mg acetylsalicylic acid (ASA) daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 500 mg acetylsalicylic acid (ASA) daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both dosage groups (40 mg and 500 mg)
Number of subjects: 40
Study: 3631421

Group type: EXPERIMENTAL
Intervention: Phosphocholinamin (nose drops)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (tap water nose drops)
Number of subjects: 12
Study: 30640027

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise group (nine-week duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 0
Study: 28797752

Group type: EXPERIMENTAL
Intervention: Incentive Spirometry (IS)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (4L·min‐1 O2 via mask)
Number of subjects: 79
Study: 26063325

Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg per week (FA10)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Folic acid 30 mg per week (FA30)
Number of subjects: 100